Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Keytruda (pembrolizumab) Powder for Injection
Company:  Merck Sharp & Dohme Corp.
Application No.:  125514
Approval Date: 9/04/2014

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: October 2, 2014

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.